<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
The stock price of Swiss pharma-giant Roche has seen a solid 12% rise over the last twenty-one trading sessions, led by multiple positive developments. Firstly, the U.S. FDA’s recent approval of Biogen’s Aduhelm for the treatment of Alzheimer’s disease has resulted in price appreciation for several.
...read full article on Forbes
